drugset / Trial / NCT01809444

Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy

NCT01809444

Phase 2/3 Unknown 146 enrolled Sun Yat-sen University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to compare the efficacy and safety of prednisone versus sub-antimicrobial dose doxycycline (50 mg/d) in the treatment of active moderate-severe Graves' Orbitopathy (GO).

Timeline

Start
2012-11
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 50 mg Oral
Comparator Prednisone Other / unclassified 10 mg